Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state-Reference-Cited by-同舟云学术

Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state

Published:2022 Issue: Volume:3 Page:100102
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Joharapurkar Amit A.^ORCID,Patel Vishal J.,Kshirsagar Samadhan G.,Patel Maulik S.,Savsani Hardikkumar H.,Kajavadara Chetan,Valani Darshan,Jain Mukul R.

Publisher

Elsevier BV

Subject

Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics

Reference48 articles.

1. Resistance of dialyzed patients to erythropoietin;Alves;Rev. Bras. Hematol. Hemoter.,2015

2. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin;Ashby;Haematologica,2010

3. Mechanisms of anemia in CKD;Babitt;J. Am. Soc. Nephrol.,2012

4. Hypoxia and inﬂammation are two sides of the same coin;Bartels;Proc. Natl. Acad. Sci. U.S.A.,2013

5. Evaluation of the carcinogenic potential of roxadustat (FG-4592), a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase in CD-1 mice and Sprague Dawley rats;Beck;Int. J. Toxicol.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice;International Immunopharmacology;2024-12

2. Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis;International Urology and Nephrology;2024-07-09

3. A Case of Erythropoietin (EPO)-Induced Pure Red Cell Aplasia and Its Treatment Efficacy With Desidustat;Cureus;2024-06-09

4. Consensus commentary and position of the Italian Society of Nephrology on KDIGO controversies conference on novel anemia therapies in chronic kidney disease;Journal of Nephrology;2024-05-06

5. The Perspective of Using Flow Cytometry for Unpuzzling Hypoxia-Inducible Factors Signalling;Drug Research;2024-02-13